PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14709903-1	2004	The aim of this study was to investigate whether the concomitant administration of the substrates or inhibitors of PEPT1, OCTN1, OCTN2, and P-glycoprotein affects the intestinal absorption of sulpiride in rats.	Sulpiride	192-201	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	140-154	
11166414-7	2001	It is speculated that the poor oral bioavailability of SP was caused by brush border P-gp efflux.	Sulpiride	55-57	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	85-89	
11166414-8	2001	Synchronous release delivery systems of SP containing also the P-gp inhibitor Qn were able to increase SP bioavailability after intestinal administration in the rat.	Sulpiride	40-42	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	63-67	
11166414-8	2001	Synchronous release delivery systems of SP containing also the P-gp inhibitor Qn were able to increase SP bioavailability after intestinal administration in the rat.	Sulpiride	103-105	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	63-67